Pub. Date : 2010 Jul
PMID : 20375898
1 Functional Relationships(s)Download |
Sentence | Compound Name | Protein Name | Organism |
| 1 | PURPOSE OF REVIEW: Dasatinib is a novel tyrosine-kinase inhibitor approved for treatment of BCR-ABL positive chronic myeloid leukemia (CML) and Philadelphia chromosome positive acute lymphoblastic leukemia (ALL) after imatinib failure. | Dasatinib | ABL proto-oncogene 1, non-receptor tyrosine kinase | Homo sapiens |